Symbols / EKSO
EKSO Chart
About
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Instruments & Su | Market Cap | 36.24M |
| Enterprise Value | 39.71M | Income | -11.92M | Sales | 12.80M |
| Book/sh | 2.54 | Cash/sh | 0.33 | Dividend Yield | — |
| Payout | 0.00% | Employees | 50 | IPO | — |
| P/E | — | Forward P/E | -53.53 | PEG | — |
| P/S | 2.83 | P/B | 4.01 | P/C | — |
| EV/EBITDA | -3.61 | EV/Sales | 3.10 | Quick Ratio | 0.98 |
| Current Ratio | 1.63 | Debt/Eq | 51.45 | LT Debt/Eq | — |
| EPS (ttm) | -5.38 | EPS next Y | -0.19 | EPS Growth | — |
| Revenue Growth | -38.30% | Earnings | 2026-05-04 | ROA | -33.62% |
| ROE | -107.62% | ROIC | — | Gross Margin | 53.48% |
| Oper. Margin | -119.71% | Profit Margin | -91.37% | Shs Outstand | 3.56M |
| Shs Float | 2.65M | Short Float | 6.41% | Short Ratio | 0.04 |
| Short Interest | — | 52W High | 13.27 | 52W Low | 2.73 |
| Beta | 0.83 | Avg Volume | 2.24M | Volume | 127.42K |
| Target Price | $9.50 | Recom | None | Prev Close | $10.64 |
| Price | $10.17 | Change | -4.42% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$9.50
Mean price target
2. Current target
$10.27
Latest analyst target
3. DCF / Fair value
$-22.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.27
Low
$9.50
High
$9.50
Mean
$9.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-31 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2025-11-18 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-07-29 | main | Lake Street | Buy → Buy | $10 |
| 2025-05-06 | main | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-03-04 | main | Lake Street | Buy → Buy | $1 |
| 2025-03-04 | reit | HC Wainwright & Co. | Buy → Buy | $9 |
| 2025-01-14 | reit | HC Wainwright & Co. | Buy → Buy | $9 |
| 2024-10-29 | main | Lake Street | Buy → Buy | $2 |
| 2024-10-29 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2024-07-30 | reit | HC Wainwright & Co. | Buy → Buy | $10 |
| 2024-06-24 | init | Lake Street | — → Buy | $3 |
| 2024-04-30 | main | HC Wainwright & Co. | Buy → Buy | $10 |
| 2024-03-05 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2024-01-22 | main | HC Wainwright & Co. | Buy → Buy | $10 |
| 2023-04-28 | reit | HC Wainwright & Co. | — → Buy | $9 |
| 2023-03-30 | reit | HC Wainwright & Co. | — → Buy | $9 |
| 2022-07-29 | main | HC Wainwright & Co. | — → Buy | $9 |
| 2020-10-30 | main | HC Wainwright & Co. | — → Buy | $11 |
| 2020-08-03 | main | Aegis Capital | — → Buy | $9 |
| 2020-06-26 | main | HC Wainwright & Co. | — → Buy | $12 |
- Major Investor Makes Bold New Move on Ekso Bionics Stock - TipRanks Sat, 21 Feb 2026 08
- Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale - Applied Digital Mon, 29 Dec 2025 08
- Beat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in Focus - Yahoo Finance Mon, 02 Feb 2026 08
- Ekso Bionics Stock Soars 103% After Applied Digital Proposes Cloud Spin-Out - Nasdaq ue, 30 Dec 2025 08
- Ekso Bionics to Acquire Cloud Unit, Rebrand ChronoScale - The Globe and Mail Wed, 18 Feb 2026 22
- Ekso Bionics (Nasdaq: EKSO) to Distribute MediTouch BalanceTutor Rehab System in U.S. - Stock Titan hu, 04 Dec 2025 08
- Ekso Bionics to Combine With Applied Digital Cloud; Issuing 138.2M Shares, Rebrands ChronoScale - TradingView ue, 17 Feb 2026 11
- $EKSO stock is down 8% today. Here's what we see in our data. - Quiver Quantitative hu, 04 Dec 2025 08
- EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders - Business Wire ue, 30 Dec 2025 08
- Marin County medical exoskeleton maker considers new direction - The Press Democrat Sat, 01 Nov 2025 07
- Ekso Bionics stock soars after becoming exclusive U.S. distributor for BalanceTutor - Investing.com hu, 04 Dec 2025 08
- How The New Price Target Is Shaping Ekso Bionics Holdings (EKSO) Story - Yahoo Finance ue, 27 Jan 2026 08
- Major Investor Quietly Boosts Position in Ekso Bionics With Fresh Stock Purchase - TipRanks Fri, 20 Feb 2026 02
- Ekso Bionics (NASDAQ: EKSO) enters registered direct; $3.7M gross at $4.81 - Stock Titan Wed, 29 Oct 2025 07
- Applied Digital to Merge Cloud Unit Into Ekso Bionics; Will Own ~97% Via 138.2M Shares - TradingView ue, 17 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1200 | 14760.0 | — | Purchase at price 12.30 per share. | ASHER DANIEL | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-19 00:00:00 | I |
| 1 | 15540 | 191162.0 | — | Purchase at price 12.30 per share. | ASHER DANIEL | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-19 00:00:00 | I |
| 2 | 102029 | 970069.0 | — | Purchase at price 8.96 - 9.96 per share. | ASHER DANIEL | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-13 00:00:00 | I |
| 3 | 1320 | 12210.0 | — | Sale at price 9.25 per share. | JONES JASON C | Chief Operating Officer | — | 2026-01-06 00:00:00 | D |
| 4 | 270 | 1269.0 | — | Sale at price 4.70 per share. | JONES JASON C | Chief Operating Officer | — | 2025-12-09 00:00:00 | D |
| 5 | 1238 | 5819.0 | — | Sale at price 4.70 per share. | WONG JEROME | Chief Financial Officer | — | 2025-12-09 00:00:00 | D |
| 6 | 23315 | 111912.0 | — | Sale at price 4.80 per share. | DAVIS SCOTT GERALD | Chief Executive Officer | — | 2025-11-10 00:00:00 | D |
| 7 | 9723 | 46670.0 | — | Sale at price 4.80 per share. | JONES JASON C | Chief Operating Officer | — | 2025-11-10 00:00:00 | D |
| 8 | 11288 | 54182.0 | — | Sale at price 4.80 per share. | WONG JEROME | Chief Financial Officer | — | 2025-11-10 00:00:00 | D |
| 9 | 80000 | — | — | Stock Award(Grant) at price 0.00 per share. | DAVIS SCOTT GERALD | Chief Executive Officer | — | 2025-11-05 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -8.85M | -13.48M | -14.70M | -12.82M |
| TotalUnusualItems | -600.00K | 279.00K | 662.00K | 4.19M |
| TotalUnusualItemsExcludingGoodwill | -600.00K | 279.00K | 662.00K | 4.19M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -11.33M | -15.20M | -15.08M | -9.76M |
| ReconciledDepreciation | 1.61M | 1.70M | 887.00K | 1.02M |
| ReconciledCostOfRevenue | 8.41M | 9.20M | 6.70M | 4.50M |
| EBITDA | -9.45M | -13.20M | -14.04M | -8.63M |
| EBIT | -11.06M | -14.90M | -14.92M | -9.65M |
| NetInterestIncome | -269.00K | -302.00K | -156.00K | -113.00K |
| InterestExpense | 269.00K | 302.00K | 156.00K | 113.00K |
| NormalizedIncome | -10.73M | -15.48M | -15.74M | -13.96M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -11.33M | -15.20M | -15.08M | -9.76M |
| TotalExpenses | 28.39M | 33.39M | 28.47M | 25.07M |
| TotalOperatingIncomeAsReported | -10.46M | -15.11M | -15.56M | -13.83M |
| DilutedAverageShares | 1.34M | 924.47K | 864.13K | 817.93K |
| BasicAverageShares | 1.34M | 924.47K | 864.13K | 812.87K |
| DilutedEPS | -8.40 | -16.50 | -17.40 | -13.20 |
| BasicEPS | -8.40 | -16.50 | -17.40 | -12.00 |
| DilutedNIAvailtoComStockholders | -11.33M | -15.20M | -15.08M | -10.79M |
| AverageDilutionEarnings | 0.00 | -1.03M | ||
| NetIncomeCommonStockholders | -11.33M | -15.20M | -15.08M | -9.76M |
| NetIncome | -11.33M | -15.20M | -15.08M | -9.76M |
| NetIncomeIncludingNoncontrollingInterests | -11.33M | -15.20M | -15.08M | -9.76M |
| NetIncomeContinuousOperations | -11.33M | -15.20M | -15.08M | -9.76M |
| PretaxIncome | -11.33M | -15.20M | -15.08M | -9.76M |
| OtherIncomeExpense | -601.00K | 216.00K | 632.00K | 4.18M |
| OtherNonOperatingIncomeExpenses | -1.00K | -63.00K | -30.00K | -17.00K |
| SpecialIncomeCharges | 0.00 | 1.10M | ||
| OtherSpecialCharges | -1.10M | |||
| ImpairmentOfCapitalAssets | 0.00 | |||
| RestructuringAndMergernAcquisition | 0.00 | |||
| GainOnSaleOfSecurity | -600.00K | 279.00K | 662.00K | 3.10M |
| NetNonOperatingInterestIncomeExpense | -269.00K | -302.00K | -156.00K | -113.00K |
| InterestExpenseNonOperating | 269.00K | 302.00K | 156.00K | 113.00K |
| OperatingIncome | -10.46M | -15.11M | -15.56M | -13.83M |
| OperatingExpense | 19.97M | 24.19M | 21.77M | 20.58M |
| ResearchAndDevelopment | 3.87M | 5.03M | 3.63M | 2.55M |
| SellingGeneralAndAdministration | 16.10M | 19.17M | 18.14M | 18.03M |
| SellingAndMarketingExpense | 7.31M | 8.47M | 7.16M | 7.30M |
| GeneralAndAdministrativeExpense | 8.79M | 10.69M | 10.99M | 10.72M |
| OtherGandA | 8.79M | 10.69M | 10.99M | 10.72M |
| GrossProfit | 9.51M | 9.08M | 6.21M | 6.75M |
| CostOfRevenue | 8.41M | 9.20M | 6.70M | 4.50M |
| TotalRevenue | 17.93M | 18.28M | 12.91M | 11.25M |
| OperatingRevenue | 16.97M | 17.92M | 11.92M | 10.43M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.48M | 989.87K | 880.20K | 846.20K |
| ShareIssued | 1.48M | 989.87K | 880.20K | 846.20K |
| TotalDebt | 5.98M | 7.17M | 7.50M | 2.22M |
| TangibleBookValue | 7.70M | 7.28M | 19.79M | 37.22M |
| InvestedCapital | 17.81M | 18.69M | 31.52M | 39.21M |
| WorkingCapital | 11.31M | 12.09M | 21.84M | 40.94M |
| NetTangibleAssets | 7.70M | 7.28M | 19.79M | 37.22M |
| CapitalLeaseObligations | 879.00K | 1.09M | 1.43M | 229.00K |
| CommonStockEquity | 12.71M | 12.61M | 25.44M | 37.22M |
| TotalCapitalization | 16.56M | 17.44M | 29.21M | 39.21M |
| TotalEquityGrossMinorityInterest | 12.71M | 12.61M | 25.44M | 37.22M |
| StockholdersEquity | 12.71M | 12.61M | 25.44M | 37.22M |
| GainsLossesNotAffectingRetainedEarnings | 957.00K | 156.00K | 563.00K | -17.00K |
| OtherEquityAdjustments | 957.00K | 156.00K | 563.00K | -17.00K |
| RetainedEarnings | -250.47M | -239.15M | -223.95M | -208.87M |
| AdditionalPaidInCapital | 262.20M | 251.58M | 248.81M | 246.09M |
| CapitalStock | 22.00K | 15.00K | 13.00K | 13.00K |
| CommonStock | 22.00K | 15.00K | 13.00K | 13.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 13.95M | 16.31M | 15.46M | 11.95M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 6.41M | 8.20M | 6.26M | 5.09M |
| OtherNonCurrentLiabilities | 181.00K | 105.00K | 141.00K | 74.00K |
| DerivativeProductLiabilities | 1.00K | 366.00K | 233.00K | 1.55M |
| NonCurrentDeferredLiabilities | 1.92M | 2.17M | 1.03M | 1.48M |
| NonCurrentDeferredRevenue | 1.92M | 2.17M | 1.03M | 1.48M |
| LongTermDebtAndCapitalLeaseObligation | 4.31M | 5.55M | 4.85M | 1.99M |
| LongTermCapitalLeaseObligation | 452.00K | 723.00K | 1.09M | 0.00 |
| LongTermDebt | 3.85M | 4.83M | 3.77M | 1.99M |
| CurrentLiabilities | 7.54M | 8.12M | 9.20M | 6.86M |
| CurrentDeferredLiabilities | 1.96M | 1.99M | 1.12M | 1.22M |
| CurrentDeferredRevenue | 1.96M | 1.99M | 1.12M | 1.22M |
| CurrentDebtAndCapitalLeaseObligation | 1.68M | 1.61M | 2.65M | 229.00K |
| CurrentCapitalLeaseObligation | 427.00K | 363.00K | 341.00K | 229.00K |
| CurrentDebt | 1.25M | 1.25M | 2.31M | |
| OtherCurrentBorrowings | 1.25M | 1.25M | 2.31M | |
| PayablesAndAccruedExpenses | 3.90M | 4.51M | 5.43M | 5.41M |
| CurrentAccruedExpenses | 2.35M | 2.66M | 2.28M | 2.30M |
| Payables | 1.55M | 1.85M | 3.15M | 3.11M |
| AccountsPayable | 1.55M | 1.85M | 3.15M | 3.11M |
| TotalAssets | 26.65M | 28.92M | 40.90M | 49.17M |
| TotalNonCurrentAssets | 7.81M | 8.71M | 9.87M | 1.37M |
| OtherNonCurrentAssets | 433.00K | 392.00K | 231.00K | 164.00K |
| GoodwillAndOtherIntangibleAssets | 5.01M | 5.32M | 5.65M | 0.00 |
| OtherIntangibleAssets | 4.58M | 4.89M | 5.22M | |
| Goodwill | 431.00K | 431.00K | 431.00K | 0.00 |
| NetPPE | 2.37M | 2.99M | 3.99M | 1.21M |
| AccumulatedDepreciation | -3.34M | -3.16M | -3.00M | -4.74M |
| GrossPPE | 5.71M | 6.15M | 6.98M | 5.95M |
| Leases | 194.00K | 178.00K | 142.00K | 631.00K |
| OtherProperties | 2.21M | 2.40M | 2.65M | 312.00K |
| MachineryFurnitureEquipment | 3.30M | 3.58M | 4.33M | 5.00M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 18.84M | 20.21M | 31.04M | 47.80M |
| OtherCurrentAssets | 541.00K | 875.00K | 700.00K | 485.00K |
| PrepaidAssets | 485.00K | |||
| Inventory | 4.57M | 5.05M | 5.19M | 2.24M |
| FinishedGoods | 843.00K | 462.00K | 863.00K | 36.00K |
| WorkInProcess | 177.00K | 290.00K | 487.00K | 145.00K |
| RawMaterials | 3.55M | 4.30M | 3.84M | 2.06M |
| Receivables | 7.24M | 5.64M | 4.62M | 4.66M |
| AccountsReceivable | 7.24M | 5.64M | 4.62M | 4.66M |
| AllowanceForDoubtfulAccountsReceivable | -33.00K | -79.00K | -40.00K | -28.00K |
| GrossAccountsReceivable | 7.27M | 5.72M | 4.67M | 4.69M |
| CashCashEquivalentsAndShortTermInvestments | 6.49M | 8.64M | 20.52M | 40.41M |
| CashAndCashEquivalents | 6.49M | 8.64M | 20.52M | 40.41M |
| CashFinancial | 6.49M | 8.64M | 20.52M | 40.41M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -9.88M | -12.21M | -14.88M | -11.21M |
| RepaymentOfDebt | -1.25M | -313.00K | 0.00 | 0.00 |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 9.02M | 661.00K | 0.00 | 37.30M |
| CapitalExpenditure | -37.00K | -157.00K | -194.00K | -59.00K |
| InterestPaidSupplementalData | 182.00K | 191.00K | 126.00K | 104.00K |
| IncomeTaxPaidSupplementalData | 8.00K | 45.00K | 13.00K | 1.00K |
| EndCashPosition | 6.49M | 8.64M | 20.52M | 40.41M |
| BeginningCashPosition | 8.64M | 20.52M | 40.41M | 12.86M |
| EffectOfExchangeRateChanges | -31.00K | -24.00K | -18.00K | 47.00K |
| ChangesInCash | -2.11M | -11.86M | -19.86M | 27.50M |
| FinancingCashFlow | 7.77M | 348.00K | 0.00 | 38.71M |
| CashFlowFromContinuingFinancingActivities | 7.77M | 348.00K | 0.00 | 38.71M |
| ProceedsFromStockOptionExercised | 0.00 | 1.42M | ||
| NetCommonStockIssuance | 9.02M | 661.00K | 0.00 | 37.30M |
| CommonStockIssuance | 9.02M | 661.00K | 0.00 | 37.30M |
| NetIssuancePaymentsOfDebt | -1.25M | -313.00K | 0.00 | 0.00 |
| NetLongTermDebtIssuance | -1.25M | -313.00K | 0.00 | 0.00 |
| LongTermDebtPayments | -1.25M | -313.00K | 0.00 | 0.00 |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -37.00K | -157.00K | -5.17M | -59.00K |
| CashFlowFromContinuingInvestingActivities | -37.00K | -157.00K | -5.17M | -59.00K |
| NetBusinessPurchaseAndSale | 0.00 | -5.00M | 0.00 | |
| PurchaseOfBusiness | 0.00 | -5.00M | 0.00 | |
| NetPPEPurchaseAndSale | -37.00K | -157.00K | -175.00K | -59.00K |
| SaleOfPPE | 0.00 | 19.00K | 0.00 | |
| PurchaseOfPPE | -37.00K | -157.00K | -194.00K | -59.00K |
| OperatingCashFlow | -9.85M | -12.05M | -14.69M | -11.16M |
| CashFlowFromContinuingOperatingActivities | -9.85M | -12.05M | -14.69M | -11.16M |
| ChangeInWorkingCapital | -2.52M | -583.00K | -2.58M | -930.00K |
| ChangeInOtherWorkingCapital | -257.00K | 1.99M | -511.00K | -564.00K |
| ChangeInPayablesAndAccruedExpense | -887.00K | -1.44M | -299.00K | 1.99M |
| ChangeInAccruedExpense | -599.00K | -134.00K | -197.00K | 379.00K |
| ChangeInPayable | -288.00K | -1.31M | -102.00K | 1.61M |
| ChangeInAccountPayable | -288.00K | -1.31M | -102.00K | 1.61M |
| ChangeInPrepaidAssets | 329.00K | -158.00K | -303.00K | 19.00K |
| ChangeInInventory | 257.00K | 232.00K | -1.40M | -752.00K |
| ChangeInReceivables | -1.97M | -1.21M | -67.00K | -1.62M |
| ChangesInAccountReceivables | -1.97M | -1.21M | -67.00K | -1.62M |
| OtherNonCashItems | -18.00K | 134.00K | ||
| StockBasedCompensation | 1.63M | 2.24M | 2.73M | 2.50M |
| ProvisionandWriteOffofAssets | 171.00K | 72.00K | 33.00K | 75.00K |
| AssetImpairmentCharge | 0.00 | |||
| DepreciationAmortizationDepletion | 1.61M | 1.70M | 887.00K | 1.02M |
| DepreciationAndAmortization | 1.61M | 1.70M | 887.00K | 1.02M |
| Depreciation | 561.00K | |||
| OperatingGainsLosses | 600.00K | -279.00K | -662.00K | -4.19M |
| GainLossOnInvestmentSecurities | -365.00K | 133.00K | -1.32M | -3.96M |
| NetForeignCurrencyExchangeGainLoss | 965.00K | -412.00K | 655.00K | 867.00K |
| NetIncomeFromContinuingOperations | -11.33M | -15.20M | -15.08M | -9.76M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for EKSO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|